Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183

References

• Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA A Cancer J Clinicians. 2014;64(2):104–117.
   PubMed Web of Science ®Google Scholar
• Acharyya S, Oskarsson T, Vanharanta S, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150(1):165–178.
   PubMed Web of Science ®Google Scholar
• Agostini M, Janssen KP, Kim IJ, et al. An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer. Oncotarget. 2015;6(32):32561–32574.
   PubMedGoogle Scholar
• Zhuo C, Wu X, Li J, et al. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer. Biosci Rep. 2018;38(4):BSR20180580.
   PubMedGoogle Scholar
• Xiao YC, Yang ZB, Cheng XS, et al. CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis. Cancer Lett. 2015;361(1):22–32.
   PubMed Web of Science ®Google Scholar
• Bai M, Chen X, Ba YI. CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer. Mol Clin Oncol. 2016;4(1):23–30.
   PubMed Web of Science ®Google Scholar
• Vicinus B, Rubie C, Stegmaier N, et al. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation. Oncol Rep. 2013;30(3):1285–1292.
   PubMed Web of Science ®Google Scholar
• Ghadjar P, Rubie C, Aebersold DM, et al. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer. 2009;125(4):741–745.
   PubMed Web of Science ®Google Scholar
• Shen T, Yang Z, Cheng X, et al. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-kappaB signaling pathway. Oncol Rep. 2017;37(4):2095–2100.
   PubMed Web of Science ®Google Scholar
• Cheng XS, Li YF, Tan J, et al. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition. Cancer Lett. 2014;348(1–2):77–87.
   PubMed Web of Science ®Google Scholar
• Arnaiz E, Sole C, Manterola L, et al. CircRNAs and cancer: biomarkers and master regulators. Semin Cancer Biol. 2018;58:90–99.
   PubMed Web of Science ®Google Scholar
• Fang S, Pan J, Zhou C, et al. Circular RNAs serve as novel biomarkers and therapeutic targets in cancers. CGT. 2019;19(2):125–133.
   Google Scholar
• Yuan Y, Liu W, Zhang Y, et al. CircRNA circ_0026344 as a prognostic biomarker suppresses colorectal cancer progression via microRNA-21 and microRNA-31. Biochem Biophys Res Comm. 2018;503(2):870–875.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Yuan D, Li K, Zhu K, et al. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Cancer Biol Ther. 2015;16(2):268–275.
   PubMed Web of Science ®Google Scholar
• Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9(3):189–198.
   PubMed Web of Science ®Google Scholar
• Pierce ML, Weston MD, Fritzsch B, et al. MicroRNA-183 family conservation and ciliated neurosensory organ expression. Evol Dev. 2008;10(1):106–113.
   PubMed Web of Science ®Google Scholar
• Abraham D, Jackson N, Gundara JS, et al. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin Cancer Res. 2011;17(14):4772–4781.
   PubMed Web of Science ®Google Scholar
• Xu X, Dong Z, Li Y, et al. The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation. Int J Biochem Cell Biol. 2013;45(3):536–545.
   PubMed Web of Science ®Google Scholar
• Earle JS, Luthra R, Romans A, et al. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. JMD. 2010;12(4):433–440.
   PubMed Web of Science ®Google Scholar
• Zhang QH, Sun HM, Zheng RZ, et al. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene. 2013;527(1):26–32.
   PubMed Web of Science ®Google Scholar
• Zhou T, Zhang GJ, Zhou H, et al. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance. Eur J Gastroenterol Hepatol. 2014;26(2):229–233.
   PubMed Web of Science ®Google Scholar
• Rong D, Sun H, Li Z, et al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017;8(42):73271–73281.
   PubMedGoogle Scholar
• Bi DP, Yin CH, Zhang XY, et al. MiR-183 functions as an oncogene by targeting ABCA1 in colon cancer. Oncol Rep. 2016;35(5):2873–2879.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ren W, Huang B, et al. MicroRNA-183/182/96 cooperatively regulates the proliferation of colon cancer cells. Mol Med Rep. 2015;12(1):668–674.
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet (London, England). 2014;383(9927):1490–1502.
   PubMed Web of Science ®Google Scholar
• Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA. 1976;73(11):3852–3856.
   PubMed Web of Science ®Google Scholar
• Peng W, Zhu S, Chen J, et al. Hsa_circRNA_33287 promotes the osteogenic differentiation of maxillary sinus membrane stem cells via miR-214-3p/Runx3. Biomed Pharmacother. 2019;109:1709–1717.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu H, Zhao P, et al. Has_circ_0055625 from circRNA profile increases colon cancer cell growth by sponging miR-106b-5p. J Cell Biochem. 2019;120(3):3027–3037.
   Google Scholar
• Fan H, Yuan R, Cheng S, et al. Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1. Biomed Pharmacother. 2018;97:1554–1563.
   PubMed Web of Science ®Google Scholar
• Wei C, Song H, Sun X, et al. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4. Oncol Rep. 2015;34(1):211–220.
   PubMed Web of Science ®Google Scholar
• Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014;7(344):re8.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang L, Wang Q, et al. MiR-183 inhibits osteosarcoma cell growth and invasion by regulating LRP6-Wnt/beta-catenin signaling pathway. Biochem Biophys Res Comm. 2018;496(4):1197–1203.
   PubMed Web of Science ®Google Scholar
• Chen Y, Song W. Wnt/catenin beta1/microRNA 183 predicts recurrence and prognosis of patients with colorectal cancer. Oncol Lett. 2018;15(4):4451–4456.
   PubMed Web of Science ®Google Scholar
• Chen C, Xiang H, Peng YL, et al. Mature miR-183, negatively regulated by transcription factor GATA3, promotes 3T3-L1 adipogenesis through inhibition of the canonical Wnt/beta-catenin signaling pathway by targeting LRP6. Cell Signal. 2014;26(6):1155–1165.
   PubMed Web of Science ®Google Scholar